Back
Pyxis Oncology Stock Predictions
Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
36
PYXS
Pyxis Oncology
Last Price:
$1.24
Seasonality Move:
-7.21%
7 Day Trial
ALL ACCESS PASS
$
7
Invest Where Innovation Meets Real Demand
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Pyxis Oncology Stock Forecast
-
Is Pyxis Oncology Stock Undervalued?The current Pyxis Oncology [PYXS] share price is $1.23. The Score for PYXS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
PYXS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Pyxis Oncology Stock Go Up Next Year?
Data Unavailable
Pyxis Oncology Stock Rating
Data Unavailable
Pyxis Oncology Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
pyxisoncology.com
52-Week Data
52-Week High:
5.39
52-Week Low:
0.83
Prediction Charts
Market Cap:
76.2M
Price in USD:
1.23
Volume:
472K
Beta:
1.13
Technical Analysis
SMA50:
1.07
SMA100:
1.24
SMA200:
2.23
52-Wk Change:
-67.8%
Stock Predictions
-
Is Pyxis Oncology stock public?Yes, Pyxis Oncology is a publicly traded company.
-
What is the Pyxis Oncology stock quote today?The Pyxis Oncology stock price is 1.23 USD today.
-
How to buy Pyxis Oncology stock online?You can buy Pyxis Oncology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-6 | 1.20 | 1.07 | 1.20 | 1.05 |
| May-7 | 1.09 | 1.07 | 1.12 | 1.06 |
| May-8 | 1.08 | 1.09 | 1.17 | 1.06 |
| May-9 | 1.11 | 1.07 | 1.17 | 1.06 |
| May-12 | 1.16 | 1.15 | 1.16 | 1.09 |
| May-13 | 1.16 | 1.19 | 1.19 | 1.11 |
| May-14 | 1.20 | 1.07 | 1.20 | 1.06 |
| May-15 | 1.08 | 1.11 | 1.11 | 1.03 |
| May-16 | 1.11 | 1.21 | 1.21 | 1.10 |
| May-19 | 1.17 | 1.23 | 1.25 | 1.16 |
| May-20 | 1.25 | 1.21 | 1.25 | 1.17 |
| May-21 | 1.20 | 1.15 | 1.22 | 1.13 |
| May-22 | 1.15 | 1.20 | 1.21 | 1.15 |
| May-23 | 1.16 | 1.23 | 1.25 | 1.16 |
Pyxis Oncology Earnings
Data Unavailable
Pyxis Oncology Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.31 per share, and an increase next year of $0.18 per share.
* Pyxis Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.